Giving their drug to the mice produced a 10-fold decrease in the number of "viable bacteria" in the liver and spleen, they said.

BBC: New weapon in superbug war

PHAs, even those made from genetically engineered bacteria, seem too expensive to be commercially viable.

ECONOMIST: Evanescent or evergreen?